Blicharski T, Sowa I, Strzemski M, Szwerc W, Majewski A. Inhibition of RANKL a key mediator of osteoclast formation – new opportunities in osteoporosis treatment. Curr. Issues Pharm. Med. Sci. 2025;24(1):179-185. Accessed June 8, 2025. https://czasopisma.umlub.pl/curipms/article/view/2993